SCHEMBL12170296

SCHEMBL12170296

COc1ccc(C2(C(C)=O)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
F10 P00742 2/20 0.49
KMT2A Q03164 2/20 0.49
TET3 O43151 1/20 0.49
FBXL19 Q6PCT2 1/20 0.49
CXXC5 Q7LFL8 1/20 0.49
TET1 Q8NFU7 1/20 0.49
KDM2B Q8NHM5 1/20 0.49
CXXC4 Q9H2H0 1/20 0.49
KDM2A Q9Y2K7 1/20 0.49
KDM4E B2RXH2 3/20 0.48
MAPT P10636 3/20 0.48
MAPK1 P28482 1/20 0.48
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13692378 0.93 CYP3A4 (0.58) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A
SCHEMBL15256583 0.91 CYP3A4 (0.57) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A
SCHEMBL8179850 0.88 F10 (0.47) ALDH1A1SMN1; SMN2CYP3A4CYP2C19F10
SCHEMBL31525688 0.88 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A
SCHEMBL301027 0.85 KMT2A (0.64) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A
SCHEMBL838025 0.83 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A
SCHEMBL837139 0.83 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2CYP3A4CYP2C19F10
SCHEMBL1480336 0.83 LMNA (0.55) ALDH1A1SMN1; SMN2CYP3A4CYP2C19F10
SCHEMBL13543198 0.80 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A
SCHEMBL13545164 0.80 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2CYP3A4CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11639347-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-05-02 US disclosed
US-20230127655-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-04-27 US disclosed
US-10022352-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-07-17 US disclosed
US-20180162842-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2018-06-14 US disclosed
US-9974781-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-05-22 US disclosed
US-9758510-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-09-12 US disclosed
US-9725440-B2 Modulators of CFTR VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-08-08 US disclosed
US-20170189389-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-06 US disclosed
US-20170107205-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-04-20 US disclosed
US-20170107206-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-04-20 US disclosed
US-20110071289-A1 AMINOPYRAZOLE AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-03-24 US disclosed
US-20110071289-A1 AMINOPYRAZOLE AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-03-24 US disclosed
US-20110060024-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-10 US disclosed
US-20100331344-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-30 US disclosed
EP-2189449-A1 AMINOPYRAZOLE AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-05-26 EP disclosed
WO-2010054138-A2 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS, INCORPORATED (US) 2010-05-14 WO disclosed
US-7309799-B2 Methods for the synthesis of milnacipran and congeners thereof COLLEGIUM PHARMACEUTICAL, INC. (US) 2007-12-18 US disclosed
WO-2007117715-A2 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-18 WO disclosed
CN-1168704-C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide 陶氏益农有限责任公司 2004-09-29 CN disclosed
CN-1262269-A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide ROHM & HAAS (US) 2000-08-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170107205-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1786/4885SMN1; SMN2 4779/4885CYP3A4 1164/4885
US-11639347-B2 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885
US-20170189389-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885
US-20180162842-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885
US-20170107206-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1786/4885SMN1; SMN2 4779/4885CYP3A4 1164/4885
US-10022352-B2 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885
US-20230127655-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885
US-20110071289-A1 AMINOPYRAZOLE AMIDE DERIVATIVE ARGLU1, ARG1, CNKSR1 ALDH1A1 280/4885SMN1; SMN2 4234/4885CYP3A4 1189/4885
US-20100331344-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885
US-20110060024-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885SMN1; SMN2 4738/4885CYP3A4 1368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.